Great article from the WSJ on taxation of medical device companies- there has never been a truer statement than the headline- "The Innovation Tax" - or the last sentence. We think this is an unfortunate effect of the U.S. government needing to finance long-overdue healthcare reforms when they are already over-extended with insurance co. and investment bank bailouts, car company rescues, and the sinking U.S. dollar (shall we go on?). We also noted an insightful sentence toward the end of the article, "the device makers simply don't have the same political clout as the other big players, making them an easier mark." AdvaMed is apparently not as politically connected as PhRMA and the likes of Merck, Pfizer, and less diversified pharmaceutical manufacturers that don't derive as much of their revenue from devices and diagnostics. Too much of the U.S. system is rooted in money/profits and influence (i.e, political'connections'.)
No comments:
Post a Comment